Chapuy Bjoern, Roemer Margaretha G M, Stewart Chip, Tan Yuxiang, Abo Ryan P, Zhang Liye, Dunford Andrew J, Meredith David M, Thorner Aaron R, Jordanova Ekaterina S, Liu Gang, Feuerhake Friedrich, Ducar Matthew D, Illerhaus Gerald, Gusenleitner Daniel, Linden Erica A, Sun Heather H, Homer Heather, Aono Miyuki, Pinkus Geraldine S, Ligon Azra H, Ligon Keith L, Ferry Judith A, Freeman Gordon J, van Hummelen Paul, Golub Todd R, Getz Gad, Rodig Scott J, de Jong Daphne, Monti Stefano, Shipp Margaret A
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands;
Blood. 2016 Feb 18;127(7):869-81. doi: 10.1182/blood-2015-10-673236. Epub 2015 Dec 23.
Primary central nervous system lymphomas (PCNSLs) and primary testicular lymphomas (PTLs) are extranodal large B-cell lymphomas (LBCLs) with inferior responses to current empiric treatment regimens. To identify targetable genetic features of PCNSL and PTL, we characterized their recurrent somatic mutations, chromosomal rearrangements, copy number alterations (CNAs), and associated driver genes, and compared these comprehensive genetic signatures to those of diffuse LBCL and primary mediastinal large B-cell lymphoma (PMBL). These studies identify unique combinations of genetic alterations in discrete LBCL subtypes and subtype-selective bases for targeted therapy. PCNSLs and PTLs frequently exhibit genomic instability, and near-uniform, often biallelic, CDKN2A loss with rare TP53 mutations. PCNSLs and PTLs also use multiple genetic mechanisms to target key genes and pathways and exhibit near-uniform oncogenic Toll-like receptor signaling as a result of MYD88 mutation and/or NFKBIZ amplification, frequent concurrent B-cell receptor pathway activation, and deregulation of BCL6. Of great interest, PCNSLs and PTLs also have frequent 9p24.1/PD-L1/PD-L2 CNAs and additional translocations of these loci, structural bases of immune evasion that are shared with PMBL.
原发性中枢神经系统淋巴瘤(PCNSL)和原发性睾丸淋巴瘤(PTL)是结外大B细胞淋巴瘤(LBCL),对当前的经验性治疗方案反应较差。为了确定PCNSL和PTL的可靶向遗传特征,我们对它们的复发性体细胞突变、染色体重排、拷贝数改变(CNA)及相关驱动基因进行了特征分析,并将这些全面的遗传特征与弥漫性LBCL和原发性纵隔大B细胞淋巴瘤(PMBL)的特征进行了比较。这些研究确定了不同LBCL亚型中遗传改变的独特组合以及靶向治疗的亚型选择性基础。PCNSL和PTL经常表现出基因组不稳定,且常出现近乎一致的双等位基因CDKN2A缺失,伴有罕见的TP53突变。PCNSL和PTL还利用多种遗传机制靶向关键基因和信号通路,并由于MYD88突变和/或NFKBIZ扩增、频繁并发的B细胞受体信号通路激活以及BCL6失调而表现出近乎一致的致癌性Toll样受体信号传导。有趣的是,PCNSL和PTL也经常出现9p24.1/PD-L1/PD-L2的CNA以及这些位点的额外易位,这是与PMBL共有的免疫逃逸结构基础。